Assessment of the clinical effectiveness of the comprehensive treatment of patients with rosacea using hepatoprotective and combined angioprotective drugs.

Abstract

Improving the treatment of rosacea is a relevant issue of modern dermatology due to the prevalence of dermatosis (rosacea is registered in 3% - 5% of the population of Ukraine) and the localization of the disease on open areas of the skin of the face, which negatively affects the psycho-emotional state of patients, reduces their work capacity and social activity. Rosacea is found to be a multifactorial chronic dermatosis, in the pathogenesis of which disorders of neuroendocrine regulation, vegetative dysfunctions, diseases of the organs of the hepatobiliary system, changes in skin microcirculation, etc., play an important role. It should be taken into account during the examination and treatment of such patients. The aim of the study. The aim of the work was to evaluate the clinical effectiveness of a comprehensive treatment of patients with rosacea using hepatoprotective and combined angioprotective drugs.